Skip to content
← Holders

Regeneron Pharmaceuticals, Inc.

What Regeneron Pharmaceuticals, Inc. reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 872589 · Filed Nov 5, 2026

Positions
3
Reported value
$179.6M
Opened
0
Closed
0
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$700.4M
    4 positions
  2. Dec 31, 2025$33.8M
    2 positions
  3. Mar 31, 2026$47.9M
    2 positions
  4. Jun 30, 2026$177.2M
    3 positions
  5. Sep 30, 2026$179.6M
    3 positions
SecuritySharesChangeValueOf portfolio
PBLSParabilis Medicines, Inc.
4.2M±0%$134.5M74.9%
NTLAIntellia Therapeutics, Inc.
3.7M±0%$44.7M24.9%
ACETAdicet Bio, Inc.
60.5K±0%$432K0.2%